We directly challenged NOS2KO animals with tumors to evaluate the effects of their specific deletion of Nos2 in the entire T-cell compartment (encompassing CD8+ and CD4+ T cells) on tumor growth (Fig. 4A). This evidence concerns the gene NOS2 and neoplasm.